Chargement en cours...
Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
BACKGROUND: Whether progression-free survival (PFS) or overall survival (OS) is the more appropriate endpoint in clinical trials of metastatic cancer is controversial. In some disease and treatment settings, an improvement in PFS does not result in an improved OS. METHODS: We partitioned OS into two...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4137232/ https://ncbi.nlm.nih.gov/pubmed/19903805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djp369 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|